Clinical Trials in Krakow, Malopolska
7 recruiting
Showing 1–7 of 7 trials
Recruiting
Phase 3
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
Follicular Lymphoma ( FL)
Regeneron Pharmaceuticals822 enrolled190 locationsNCT06091254
Recruiting
Phase 3
A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
Relapsed/Refractory Follicular LymphomaRelapsed/Refractory Marginal Zone Lymphoma (R/R MZL)
Regeneron Pharmaceuticals470 enrolled168 locationsNCT06149286
Recruiting
Occupational Situation and Return to Work of Urological Patients
Prostate CancerBladder CancerRenal Cancer+1 more
Jagiellonian University2,000 enrolled1 locationNCT07088536
Recruiting
Phase 4
Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma
Asthma
Regeneron Pharmaceuticals250 enrolled84 locationsNCT06572228
Recruiting
Post-traumatic Stress Disorder in Spontaneous Abortion
Spontaneous Abortion
Jagiellonian University200 enrolled1 locationNCT07306676
Recruiting
Voiding and Erectile Function After Retroperitoneal Lymph Node Dissection for Testicular Cancer
Testicular Cancer
Jagiellonian University20 enrolled1 locationNCT06954233
Recruiting
Phase 1
Immunotherapy With Dinutuximab Beta in Combination With Chemotherapy for the Treatment of Patients With Primary Neuroblastoma Refractory to Standard Therapy and With Relapsed or Progressive Disease
High Risk Neuroblastoma
Jagiellonian University20 enrolled1 locationNCT05272371